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Monitoring the depth of hypnosis (DoH) in anesthetized patients provides the anesthe-siologist with significant additional infor-
mation, enabling one to adjust the dose of anesthetic 
agents more adequately, according to the needs of the 
patient. DoH monitoring in children has been shown 
to result in the use of lower doses of anesthetic drugs 
and a faster recovery.1–3 Bearing in mind the ongoing 
discussion about potential neurotoxic effects of anes-
thetic drugs on the developing brain, this technology 
can help prevent anesthetic drug overdosing, adding 
safety to the conduct of pediatric anesthesia.
Mid-latency auditory evoked potentials (MLAEP) 
can be utilized to measure the DoH during anesthe-
sia.4–7 The developmental time of MLAEP extends 
through the first decade of life,8 as opposed to the raw 
electroencephalogram (EEG), which is not mature 
before early adulthood. MLAEP are therefore a poten-
tially more useful parameter to assess the DoH than 
EEG in children.
The aepEXplus monitor (aepEX) is a commer-
cially available DoH monitor that utilizes MLAEP. 
In previous studies, the performance of the aepEX 
KEY POINTS
• Question: How does the aepEX monitor perform in detecting different depths of hypnosis in 
children during desflurane-remifentanil anesthesia?
• Findings: This study demonstrates that the aepEX monitor has reasonable sensitivity and 
high specificity to detect the return of consciousness while having a low prediction probability 
of distinguishing different depths of hypnosis.
• Meaning: The aepEX monitor can reliably be used as an additional parameter to detect the 
return of consciousness in children receiving desflurane-remifentanil anesthesia.
BACKGROUND: The aepEXplus monitoring system, which uses mid-latency auditory evoked 
potentials to measure depth of hypnosis, was evaluated in pediatric patients receiving desflu-
rane-remifentanil anesthesia.
METHODS: Seventy-five patients, 1–18 years of age (stratified for age; 1–3, 3–6, 6–18 years, for 
subgroup analyses), were included in this prospective observational study. The aepEX and the 
bispectral index (BIS) were recorded simultaneously, the latter serving as a reference. The abil-
ity of the aepEX to detect different levels of consciousness, defined according to the University 
of Michigan Sedation Scale, investigated using prediction probability (Pk), and receiver operating 
characteristic (ROC) analysis, served as the primary outcome parameter. As a secondary out-
come parameter, the relationship between end-tidal desflurane and the aepEX and BIS values 
were calculated by fitting in a nonlinear regression model.
RESULTS: The Pk values for the aepEX and the BIS were, respectively, .68 (95% CI, 0.53–0.82) 
and .85 (95% CI, 0.73–0.96; P = .02). The aepEX and the BIS had an area under the ROC 
curve of, respectively, 0.89 (95% CI, 0.80–0.95) and 0.76 (95% CI, 0.68–0.84; P = .04). The 
maximized sensitivity and specificity were, respectively, 81% (95% CI, 61%–93%) and 86% (95% 
CI, 74%–94%) for the aepEX at a cutoff value of >52, and 69% (95% CI, 56%–81%) and 70% 
(95% CI, 57%–81%) for the BIS at a cutoff value of >65. The age-corrected end-tidal desflurane 
concentration associated with an index value of 50 (EC50) was 0.59 minimum alveolar concen-
tration (interquartile range: 0.38–0.85) and 0.58 minimum alveolar concentration (interquartile 
range: 0.41–0.70) for, respectively, the aepEX and BIS (P = .69). Age-group analysis showed no 
evidence of a difference regarding the area under the ROC curve or EC50.
CONCLUSIONS: The aepEX can reliably differentiate between a conscious and an uncon-
scious state in pediatric patients receiving desflurane-remifentanil anesthesia.  (Anesth Analg 
2020;130:194–200)
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was evaluated in children during propofol and 
sevoflurane anesthesia.9,10 Desflurane, due to its low 
blood-gas partition coefficient, has a unique pharma-
cokinetic profile, which, from a clinical perspective, 
can best be described as “fast in-fast out.” Desflurane 
is a challenging drug for DoH monitors because they 
have to calculate their DoH indices in a clinical setting 
characterized by fast changes in hypnotic drug target 
concentration.
The current study was conducted to assess the 
performance of the aepEX monitor in children dur-
ing desflurane-remifentanil anesthesia. For means 
of reference, bispectral index (BIS) values were also 
recorded simultaneously.
The primary objective of this prospective observa-
tional study was to assess the ability of the aepEX to 
detect the return of consciousness during emergence 
from anesthesia. Our secondary objective was to 
assess the relationship between the aepEX and differ-
ent end-tidal desflurane concentrations.
METHODS
This article adheres to the applicable STrengthening the 
Reporting of OBservational studies in Epidemiology 
(STROBE)  guideline. The study was reviewed and 
approved on May 12, 2011 by the Institutional Review 
Board of the Erasmus MC, Rotterdam, the Netherlands 
(MEC 2011–104, NL 35976.078.11) and registered in the 
Dutch trial register before inclusion of the first patient 
(http://www.trialregister.nl/trialreg/admin/rctview.
asp?TC=2983, NTR2983, principal investigator: Y. M. 
Cheung, date of registration: July 12, 2011). Written 
informed consent was obtained from the participants’ 
parents or guardians. According to the Dutch law, addi-
tional written informed assent was collected from chil-
dren ≥12 years of age.
Patients scheduled in the Erasmus MC, Sophia 
children’s hospital for elective general, urologic, plas-
tic, or orthopedic surgery were eligible for inclusion. 
The entire cohort of 75 patients was stratified for 
age into 3 groups of 25 children each (group 1: 1–3 
years; group 2: 3–6 years; and group 3: 6–18 years) to 
detect possible age-related effects. Exclusion criteria 
consisted of known allergies to any medication in the 
study protocol (remifentanil, desflurane, sevoflurane, 
and/or propofol), the presence of a clinically signifi-
cant hearing impairment, the use of medication (eg, 
premedication, antiepileptics), having a condition 
affecting the EEG (to prevent bias), and a planned 
postoperative admittance to the pediatric intensive 
care unit.
Conduct of Anesthesia
After arrival at the operating room, an intravenous 
cannula was inserted and remifentanil 0.5 µg·kg−1 
was administered over 15 seconds followed by a 
continuous infusion of 0.1 µg·kg−1·minute−1. General 
anesthesia was induced with propofol 3.0–5.0 mg·kg−1.
When it was not possible to obtain intravenous 
access in the awake child, induction was performed 
with sevoflurane by facemask, after which an intra-
venous access was obtained in the anesthetized child. 
Immediately after an intravenous cannula was in 
place, remifentanil was administered according to 
the same scheme as in awake children. After insertion 
of a laryngeal mask, airway desflurane was slowly 
washed in to an end-tidal desflurane concentration 
(Etdes) of approximately 1 minimum alveolar concen-
tration (MAC), adjusted for age.11
Once the airway was secured, locoregional anal-
gesia was given whenever possible and appropriate. 
Ropivacaine 0.2% was used for low-volume ultrasound-
guided peripheral locoregional techniques and caudal 
blocks. Penile nerve blocks were performed with bupi-
vacaine 0.5%. When locoregional analgesia was not an 
option, for whatever reason, remifentanil was increased 
to a dose of 0.3–0.4 µg·kg−1·minute−1 during the surgery.
During anesthesia, all patients were monitored 
with our standard equipment, which consists of elec-
trocardiogram, pulse oximetry, noninvasive blood 
pressure measurement, temperature, capnography, 
and inspired and end-tidal concentrations of oxygen, 
sevoflurane, and desflurane.
aepEX and BIS Monitoring
After induction of general anesthesia, the skin on the 
forehead was swabbed with alcohol and abraded with 
Sensor Prep (Medical Device Management, Essex, United 
Kingdom) to decrease the impedance to a low enough 
level to allow for both aepEX and BIS monitoring. aepEX 
and BIS electrodes were then attached, respectively, on 
the left and right sides of the patient’s forehead accord-
ing to the manufacturer’s recommendation. A commer-
cially available over-the-ear headphone (MDR-V150; 
Sony Europe, London, United Kingdom) was connected 
to the aepEX because standard earplugs are unsuitable 
for small children. aepEX index values were transferred 
to a personal computer at 5-second intervals using the 
aepEX’s logger software (version 1.3, Medical Device 
Management, Essex, United Kingdom). aepEX data 
labeled with “artefact,” as shown by the aepEX logger 
software, were excluded from subsequent analysis.
The BIS Vista monitoring system (version 2.02, Aspect 
Systems International, de Meern, the Netherlands) was 
used, with a smoothing rate of 15 seconds. BIS data 
were directly transferred at 1-second intervals to a USB 
stick plugged into the monitor. BIS values with a sig-
nal quality <50%, as indicated by the BIS signal quality 
index, were excluded from subsequent analysis.
Data collection for study purposes started 15 minutes 
after administration of propofol or when the end-tidal 
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sevoflurane concentration, in the case of an inhala-
tion induction, was 0% as measured by our anesthesia 
machine (Primus, Draeger, Lübeck, Germany). Patients 
were primarily allowed to breathe spontaneously dur-
ing the surgical procedure. In case of hypoventilation 
(end-tidal CO2 >6.0 kPa), mechanical ventilation was 
used to reestablish and maintain normocapnia (end-
tidal CO2 of 4.5–6.0 kPa). During the surgical procedure, 
Etdes was initially titrated to 1.5 MAC and decreased 
every 3 minutes by 1 vol% to a minimum of 0.7 MAC, 
corrected for age. According to Taylor and Lerman,11 we 
defined 1 MAC as 8.7%, 8.6%, 8.0%, and 7.5% for chil-
dren 1–3, 3–5, 5–12, and ≥12 years of age. At the start of 
wound closure, Etdes was decreased to 0.5 MAC. After 
completion of the surgical procedure, the administra-
tion of desflurane was discontinued, and the fresh-gas 
flow was set to 10 L·minute−1 using 100% oxygen.
During the emergency period, the DoH was 
assessed according to the University of Michigan 
Sedation Scale (UMSS)12 until the patient had a UMSS 
≤1. The UMSS consists of 5 levels, including “awake/
alert,” “minimally sedated,” “moderately sedated,” 
“deeply sedated,” and “unarousable,” which corre-
spond, respectively, to a UMSS of 0, 1, 2, 3, and 4.
Data analyses were performed with the average 
index value over 10 seconds before the intended time 
points as described previously.
Statistical Analysis
Primary Outcome. The relationship between the index 
values and different DoH (UMSS) were analyzed 
by calculating the prediction probability value (Pk), 
which was described by Smith et al.13 A Pk value 
and the area under the curve (AUC) derived from 
a receiver operating characteristic (ROC) analysis 
are both measures of the discriminative ability of a 
predictor; to set it more precisely, Pk is a generalization 
of the AUC. ROC analyses can only be performed 
with dichotomous outcome parameters, whereas Pk 
also allows assessment of the discriminative power 
of a predictor when there are >2 states. A Pk of 1.0 
corresponds with a DoH monitor that always predicts 
the correct UMSS. If a DoH monitor predicts the correct 
UMSS in only 50% of the cases, then it will have a Pk 
of .5. A Pk <.5 describes an inverse relationship. An 
inverse relationship will be expressed as 1 − Pk for a 
better understanding. Pk values were only computed 
when ≥3 different UMSS values were observed 
because computing this for only 2 different values 
would be the same as a ROC with its corresponding 
AUC. For each individual patient, the Pk value would 
be computed, after which the mean Pk value for its 
corresponding age group would be calculated.
ROC analyses and its corresponding AUC were 
performed to investigate the predictive capabilities of 
the DoH monitor to distinguish consciousness from 
unconsciousness using MedCalc for Windows, ver-
sion 5.6.1 (MedCalc Software, Mariakerke, Belgium). 
The cutoff index value at which both the sensitivity 
and the specificity was the highest was defined as the 
maximized combination. For analysis, we defined 
consciousness and unconsciousness as a UMSS of, 
respectively, ≤1 and ≥2.
Secondary Outcome. aepEX and BIS data were fitted 
in a nonlinear regression model to analyze the 
relationship between index values and different Etdes. 














E0 and Emax are, respectively, the minimum and max-
imum value of the index values, which were 0 and 
100. The EC50 is the Etdes at which an index value of 50 
was reached on the DoH monitors. E is the predicted 
index value during the administration of an Etdes of 
x , whereas γ  is the Hillslope, which was variable to 
optimize the best fit for this model. The EC50 of each 
individual patient was first computed after which the 
median of the corresponding group was calculated.
Continuous data were tested for normality by 
visual inspection and the D’Agostino & Pearson 
omnibus normality test. To compare the EC50 between 
the aepEX and BIS (of the cohort and different age 
groups), the Wilcoxon matched-pairs signed rank test 
was used. When comparing the EC50 among different 
age groups, a Kruskal-Wallis test was used. Pk values 
of the aepEX and BIS (of the cohort and different age 
groups) were compared with a paired t test, while Pk 
values among different age groups were analyzed 
with an unpaired t test. These tests were computed 
and analyzed with GraphPad Prism for Windows, 
version 6.04 (GraphPad Software, San Diego, CA). 
The method of DeLong et al14 was applied for analy-
sis of the (paired) AUC between the aepEX and BIS 
monitor. The comparison of the AUC of different age 
groups was made according to the method of Hanley 
and McNeil.15 All analyses among or within the 3 age 
groups were corrected for multiple testing with the 
Bonferroni correction, except for the Kruskal-Wallis 
test, for which Dunn’s post hoc analysis was applied.
Descriptive analyses were performed with IBM 
SPSS Statistics for Windows, version 21.0 (IBM Corp, 
Armonk, NY). Variables were presented as mean ± 
standard deviation unless stated otherwise. P values 
<.05 were considered statistically significant.
A sample size of 25 children per age group and the 
defined age groups correspond to similar published 
studies concerning DoH monitors.6,16,17 Previous stud-
ies have assumed that a reliable Pk value can be com-
puted with a sample size of >20 patients.18–20
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RESULTS
Between December 2012 and September 2014, 
a total of 75 patients were included, of whom 7 
had to be excluded secondarily due to the fol-
lowing reasons: administration of premedi-
cation (N = 1, group 2), tracheal intubation 
(N = 1, group 1), and ventilation difficulties before 
or during the data collection (N = 4, group 1; N = 1, 
group 3). Details concerning baseline characteristics 
of the patient are shown in Table 1.
During the wash-in period of desflurane, 28 patients 
(N = 11, group 1; N = 8, group 2; N = 9, group 3) had dif-
ficulties maintaining normocapnia, despite mechani-
cal ventilation. In these patients, a further increase of 
desflurane was avoided, and intraoperative measure-
ments were started at an end-tidal desflurane con-
centration <1.5 MAC. In another 3 patients (N = 1, 
group 1; N = 2, group 2), the target MAC of 1.5 could 
not be reached due to an unexpected short surgical 
procedure. Furthermore, we were unable to collect 
data until a UMSS of 1 was reached in 3 patients (N 
= 2, group 2; N = 1, group 3) due to patient agitation 
during emergence. In 1 patient (group 3), the aepEX 
could not compute any index values due to excessive 
artifact contamination of the signal. From this patient, 
only BIS values from the emergency period were 
available for analysis.
Data during emergence were available in 45 patients 
in which ≥3 UMSS values could be observed. The 
Table 1.  Baseline Characteristics
Characteristics 1–3 y (N = 20) 3–6 y (N = 24) 6–18 y (N = 24)
Entire Cohort  
(N = 68)
Female, no. (%) 1 (5) 2 (8) 7 (29) 10 (15)
Age, median [range] (mo) 22 [12–35] 54 [37–70] 139 [73–210] 74 [12–210]
Weight, median (IQR) (kg) 12 (10–15) 17 (15–21) 44 (26–59) 17 (14–26)
Procedure, no. (%)
 Upper extremity 3 (15) 3 (13) 5 (21) 11 (16)
 Subumbilical 17 (85) 20 (83) 19 (79) 56 (82)
 Upper and lower extremity 0 (0) 1 (4) 0 (0) 1 (1)
Locoregional analgesia technique, no. (%)
 Caudal 17 (85) 16 (67) 9 (38) 42 (62)
 Brachial plexus 1 (5) 2 (8) 2 (8) 5 (7)
 Lumbosacral plexus 0 (0) 2 (8) 10 (42) 12 (18)
 Epidural 0 (0) 1 (4) 0 (0) 1 (1)
 None 2 (10) 3 (13) 3 (13) 8 (12)
Abbreviation: IQR, interquartile range.
Figure 1. aepEXplus monitor’s (aepEX) receiver operating character-
istic. Sensitivity (solid red lines) and specificity (solid blue lines) at 
different aepEX cutoff values with their respective 95% CIs (dotted 
red and blue lines).
Table 2.  Receiver Operator Characteristics 
Analysis of the aepEX and BIS Monitor
Age Group
AUC of the aepEX  
(Mean: 95% CI)
AUC of the BIS  
(Mean: 95% CI) P Value
Group 1 0.76 (0.55–0.90) 0.63 (0.42–0.81) .31a
Group 2 0.95 (0.79–1.00) 0.84 (0.64–0.95) .05a
Group 3 0.99 (0.85–1.00) 0.98 (0.84–1.00) .87a
Entire cohort 0.89 (0.80–0.95) 0.76 (0.68–0.84) .04
Abbreviations: aepEX, aepEXplus monitor; AUC, area under the curve; BIS, 
bispectral index; CI, confidence interval. 
aUncorrected P value for multiple testing.
Figure 2. Bispectral index’s (BIS) receiver operating characteristic. 
Sensitivity (solid red lines) and specificity (solid blue lines) at different BIS 
cutoff values with their respective 95% CIs (dotted red and blue lines).
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quality of the EEG signal was sufficient to compute 13 
Pk values for the aepEX and 37 for the BIS. A paired t 
test was possible in 12 Pk data pairs, resulting in a Pk 
value of .68 (95% CI, 0.53–0.82) for the aepEX and 0.85 
(95% CI, 0.73–0.96) for the BIS (P = .02). Because only 
12 pairs of Pk values were available for analysis, a sub-
sequent age-group analysis was abandoned.
The maximized combination of sensitivity and 
specificity of the aepEX was 81% (95% CI, 61%–93%) 
and 86% (95% CI, 74%–94%) at an index value >52. 
This was for the BIS at an index value of >65, dur-
ing which the sensitivity was 69% (95% CI, 56%–81%) 
and the specificity 70% (95% CI, 57%–81%). A detailed 
relationship between index value and sensitivity and 
specificity are plotted in Figures 1 and 2.
Paired comparisons of the AUC of the aepEX and BIS 
monitor showed no evidence for a difference between 
the entire cohort or the different age groups. Details 
are shown in Table 2. We also found no evidence of a 
difference when comparing AUCs of the 3 age groups 
with each other after correction for multiple testing.
A total of 569 aepEX values qualified for subsequent 
analysis (having no artifacts), while the BIS provided 
632 index values with a signal quality of >50%. These 
values are plotted in Figure 3, describing the relation-
ship between the index values of both DoH monitors 
during different Etdes and UMSS.
The age-corrected EC50 for the aepEX (EC50aepEX) was 
0.59 MAC (interquartile range: 0.38–0.85; N = 57) and for 
the BIS (EC50BIS) 0.58 MAC (interquartile range: 0.41–0.70; 
N = 63). Eleven EC50aepEX could not be computed due 
to software limitations (unable to converge data; N = 2, 
group 1; N = 1, group 2; N = 1, group 3), too few intraop-
erative data (N = 1, group 1; N = 1, group 2; N = 1, group 
3), and data with too many artifacts (N = 3, group 2; 
N = 1, group 3). Software limitations accounted for 2 
missing EC50BIS (N = 1, group 1; N = 1, group 3) and 3 for 
having too few intraoperative data (N = 1, group 1; N = 1, 
group 2; N = 1, group 3). Both monitors had a comparable 
r2: 0.62 (95% CI, 0.54–0.71) for the aepEX and 0.69 (95% 
CI, 0.63–0.76) for the BIS. The Kruskal-Wallis tests com-
paring the EC50 among different age groups also showed 
no evidence of a difference (P = .27 for the aepEX and 
P = .12 for the BIS). Paired comparison (N = 57) between 
the EC50aepEX and EC50BIS resulted in a P value of .69. The 
same comparison for age groups 1, 2, and 3 revealed 
P values of, respectively, .38, .14, and .84.
DISCUSSION
Our study demonstrates that the aepEX monitor 
differentiates between unconscious and conscious 
pediatric patients with a 10% higher sensitivity and 
specificity than the BIS monitor. As opposed to this 
finding, the aepEX performs inferiorly to the BIS to 
correctly predict different UMSS. We found no evi-
dence of an age-related difference in performance 
of the aepEX, suggesting that the aepEX performs 
equally in all patients from 1 to 18 years of age.
The results of this study are consistent with our 
findings from the previous study investigating the 
Figure 3. Trend of aepEXplus monitor (aepEX) and bispectral index (BIS). Mean index values of the aepEX (solid lines) and BIS (dashed lines) 
with their respective 95% CIs related to different end-tidal desflurane concentrations and University of Michigan Sedation Scale (UMSS) val-
ues. MAC indicates minimum alveolar concentration.
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aepEX in children during propofol and sevoflurane 
anesthesia.9,10 This finding implies that the aepEX 
monitor also performs equally during different com-
monly used anesthetics in children, that is, propofol, 
sevoflurane, and desflurane.
As proposed by Smith et al,13 the Pk approach to 
measure the performance of an anesthetic depth indi-
cator is aimed to include different levels of anesthetic 
depth in the analysis. We could, however, only mea-
sure 2 levels of anesthetic depth in the majority of our 
patients, which is probably attributable to the proper-
ties of desflurane, for example, its low blood-gas par-
tition coefficient. Nonetheless, we found evidence of 
the superiority of the BIS over the aepEX in discrimi-
nating different UMSS levels.
The concept that consciousness has levels has been 
accepted for decades. Many different clinical observa-
tional scales have been designed, validated, and used 
to assess the level of consciousness, among them the 
Observer’s Assessment of Alertness/Sedation scale 
and the UMSS. All of these scales assume that DoH is 
graded and that, beginning with a fully awake subject, 
each step of the scale reflects a “lower level of con-
sciousness,” or, in the context of anesthesia research, 
“depth of hypnosis.” By now we are still not sure 
about the true underlying mechanism(s) of our men-
tal states named consciousness and unconsciousness. 
Regarding unconsciousness, it is even possible that 
the concept of “hypnotic depth” is not correct at all, 
in other words, that we are either conscious or uncon-
scious.21 Therefore, we also performed an ROC analy-
sis as an alternative approach to quantify the monitors’ 
performance. An ROC analysis requires only 2 differ-
ent states (“conscious” and “unconscious”) for analy-
sis. Beside this, it also gives a more clinically applicable 
result, that is, a clear cutoff value with its correspond-
ing sensitivity and specificity. In our current study, we 
found that when choosing the maximal sensitivity and 
specificity, the aepEX is superior to the BIS. Choosing 
the clinically most relevant combination of the sensitiv-
ity and specificity of the monitors depends on personal 
preferences regarding the most important monitoring 
target. When prevention of intraoperative awareness 
is of paramount importance, a DoH monitor with a 
higher sensitivity is favorable. However, if the sensi-
tivity is chosen too high, the resulting low specificity 
would render the monitor useless (Figures 2–3).
By definition, the EC50 is the drug concentration 
needed to achieve 50% of the drug’s maximum effect. 
In our current study, we fitted our intraoperative data 
in a nonlinear regression model to compute the EC50. 
However, the EC50 can also be measured by recording 
the end-tidal desflurane concentration while main-
taining an index value of 50. Fletcher et al17 performed 
such a study by maintaining a BIS of 60 during pediat-
ric scoliosis surgery under desflurane anesthesia. The 
end-tidal concentration desflurane needed to main-
tain a BIS of 60 can be described as an EC60 for the BIS 
monitor. Although an EC60 is different from an EC50 
and our study designs are not comparable, we found 
a similar MAC of 0.58. Caution is needed when com-
paring both studies; despite the aforementioned, their 
EC60 comes close to the EC50BIS we observed.
Although processed EEG and MLAEP have strong 
relationships with consciousness level, we should not 
solely rely on computed DoH index values. A recent 
study by Schneider et al22 supports this concept. They 
demonstrated that the combination of the BIS moni-
tor with other standard monitoring parameters, for 
example, heart rate and blood pressure, resulted in a 
Pk of 1.0 to detect the return of consciousness in adult 
patients, emphasizing the importance of observing 
the patient as a whole.
Almost all patients in our study received additional 
locoregional analgesia before the surgical procedure, 
most often a caudal block. Davidson et al16 demonstrated 
that a caudal block resulted in a decrease in BIS value of 
5 points. The effect of a caudal block on the aepEX has 
not yet been studied. Although remifentanil decreases 
the MAC of volatile anesthetics, the DoH seems to be 
unaffected by it, which was demonstrated by Schraag et 
al and Guignard et al.23,24 Both studies observed no effect 
of remifentanil on the aepEX and BIS index values, and 
we assume that this also applies for our study.
Other studies have revealed a Pk BIS value of .82 
and .89, which is similar to our observed Pk value of 
.85.25,26 However, these results were observed in the 
adult population and concerned Pk values detect-
ing different end-tidal desflurane concentrations or 
eye opening after general anesthesia. Because our 
observed Pk BIS value is not comparable to other stud-
ies and only 13 paired Pk values could be computed 
in our study, interpretations of the Pk values of the 
aepEX and BIS are limited.
The age stratification applied in this study was 
designed to match similar studies for comparison pur-
poses. However, concerns can be made due to the broad 
range of group 3 (6–18 years of age). Because the MLAEP 
is still developing until the first decade of life,8 this 
group consisted of children with developing MLAEP 
and fully developed MLAEP pathways. However, 
because the development of the MLAEP is a continu-
ous process, we would at least expect to find a differ-
ence between group 1 (fully undeveloped MLAEP) and 
group 3 (MLAEP in final development combined with 
fully developed MLAEP) if an age-dependent perfor-
mance for the aepEX exists. It would be interesting to 
compare group 3 with adult data, but unfortunately no 
such comparable study was published.
Our study population consisted predominantly of 
male children. However, we believe it is unlikely that 
this factor affected our study.
Copyright © 2018 International Anesthesia Research Society. Unauthorized reproduction of this article is prohibited.
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In conclusion, our current study observed that the 
aepEX monitor could reliably differentiate unconscious-
ness from consciousness in pediatric patients during 
remifentanil-desflurane anesthesia combined with a 
locoregional technique. E
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